NVCR FY 2019 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

FY 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$351M+41.6% YoY

Gross Profit

$263M74.8% margin

Operating Income

-$914,000-0.3% margin

Net Income

-$7M-2.1% margin

EPS (Diluted)

$-0.07

Cash Flow

Operating Cash Flow

$27M

Free Cash Flow

$16M

Stock-Based Comp.

$52M

Balance Sheet

Total Assets

$479M

Total Liabilities

$262M

Stockholders' Equity

$218M

Cash & Equivalents

$179M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$351M	$248M	+41.6%
Gross Profit	$263M	$168M	+56.4%
Operating Income	-$914,000	-$34M	+97.3%
Net Income	-$7M	-$64M	+88.6%